Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms von Kampa-Schittenhelm, Kerstin Maria, Heinrich, Michael Charles, Akmut, Figen, Döhner, Hartmut, Döhner, Konstanze, Schittenhelm, Marcus Matthias

Volltext

Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia von Kampa-Schittenhelm, Kerstin Maria, Heinrich, Michael Charles, Akmut, Figen, Rasp, Katharina Henriette, Illing, Barbara, Döhner, Hartmut, Döhner, Konstanze, Schittenhelm, Marcus Matthias

Volltext

High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib von Al-Ali, Haifa-Kathrin, Heinrich, Michael Charles, Lange, Thoralf, Krahl, Rainer, Mueller, Matthias, Müller, Christel, Niederwieser, Dietger, Druker, Brian James, Deininger, Michael Werner Nikolaus

Volltext

Expression of interest for the CODEX-b detector von Aielli, Giulio, Ben-Haim, Eli, Cardarelli, Roberto, Charles, Matthew John, Cid Vidal, Xabier, Coco, Victor, Dey, Biplab, Dumps, Raphael, Evans, Jared A., Gibbons, George, Dortz, Olivier Le, Gligorov, Vladimir V., Ilten, Philip, Knapen, Simon, Lee, Jongho, López Soliño, Saul, Nachman, Benjamin, Papucci, Michele, Polci, Francesco, Quessard, Robin, Ramani, Harikrishnan, Robinson, Dean J., Schindler, Heinrich, Sokoloff, Michael D., Swallow, Paul, Vari, Riccardo, Watson, Nigel, Williams, Mike

Volltext

A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation von Dittmann, Meike, Hoffmann, Hans-Heinrich, Scull, Margaret A., Gilmore, Rachel H., Bell, Kierstin L., Ciancanelli, Michael, Wilson, Sam J., Crotta, Stefania, Yu, Yingpu, Flatley, Brenna, Xiao, Jing W., Casanova, Jean-Laurent, Wack, Andreas, Bieniasz, Paul D., Rice, Charles M.

Volltext

Replication and single-cycle delivery of SARS-CoV-2 replicons von Ricardo-Lax, Inna, Luna, Joseph M., Thao, Tran Thi Nhu, Le Pen, Jeremie, Yu, Yingpu, Hoffmann, H-Heinrich, Schneider, William M., Razooky, Brandon S., Fernandez-Martinez, Javier, Schmidt, Fabian, Weisblum, Yiska, Trueb, Bettina Salome, Veiga, Ines Berenguer, Schmied, Kimberly, Ebert, Nadine, Michailidis, Eleftherios, Peace, Avery, Sanchez-Rivera, Francisco J., Lowe, Scott W., Rout, Michael P., Hatziioannou, Theodora, Bieniasz, Paul D., Poirier, John T., MacDonald, Margaret R., Thiel, Volker, Rice, Charles M.

Volltext

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor von HEINRICH, Michael C, MAKI, Robert G, FLETCHER, Christopher D. M, XIN HUANG, COHEN, Darrel P, BAUM, Charles M, DEMETRI, George D, CORLESS, Christopher L, ANTONESCU, Cristina R, HARLOW, Amy, GRIFFITH, Diana, TOWN, Ajia, MCKINLEY, Arin, OU, Wen-Bin, FLETCHER, Jonathan A

Volltext

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit... von BLANKE, Charles D, RANKIN, Cathryn, TANAKA, Michael, HECHT, J. Randolph, HEINRICH, Michael C, FLETCHER, Christopher D. M, CROWLEY, John J, BORDEN, Ernest C, DEMETRI, George D, RYAN, Christopher W, VON MEHREN, Margaret, BENJAMIN, Robert S, RAYMOND, A. Kevin, BRAMWELL, Vivien H. C, BAKER, Laurence H, MAKI, Robert G

Volltext

Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Ex... von BLANKE, Charles D, DEMETRI, George D, WEHRE, Elisabeth, NIKOLOVA, Zariana, JOENSUU, Heikki, VON MEHREN, Margaret, HEINRICH, Michael C, EISENBERG, Burton, FLETCHER, Jonathan A, CORLESS, Christopher L, FLETCHER, Christopher D. M, ROBERTS, Peter J, HEINZ, Daniela

Volltext

Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity von Swanson, Michael D., Boudreaux, Daniel M., Salmon, Loïc, Chugh, Jeetender, Winter, Harry C., Meagher, Jennifer L., André, Sabine, Murphy, Paul V., Oscarson, Stefan, Roy, René, King, Steven, Kaplan, Mark H., Goldstein, Irwin J., Tarbet, E. Bart, Hurst, Brett L., Smee, Donald F., de la Fuente, Cynthia, Hoffmann, Hans-Heinrich, Xue, Yi, Rice, Charles M., Schols, Dominique, Garcia, J. Victor, Stuckey, Jeanne A., Gabius, Hans-Joachim, Al-Hashimi, Hashim M., Markovitz, David M.

Volltext

Non-coding deletions identify Maenli lncRNA as a limb-specific En1 regulator von Allou, Lila, Balzano, Sara, Magg, Andreas, Quinodoz, Mathieu, Royer-Bertrand, Beryl, Schöpflin, Robert, Chan, Wing-Lee, Speck-Martins, Carlos E., Carvalho, Daniel Rocha, Farage, Luciano, Lourenço, Charles Marques, Albuquerque, Regina, Rajagopal, Srilakshmi, Nampoothiri, Sheela, Campos-Xavier, Belinda, Chiesa, Carole, Niel-Bütschi, Florence, Wittler, Lars, Timmermann, Bernd, Spielmann, Malte, Robson, Michael I., Ringel, Alessa, Heinrich, Verena, Cova, Giulia, Andrey, Guillaume, Prada-Medina, Cesar A., Pescini-Gobert, Rosanna, Unger, Sheila, Bonafé, Luisa, Grote, Phillip, Rivolta, Carlo, Mundlos, Stefan, Superti-Furga, Andrea

Volltext

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radi... von Wang, Dian, Zhang, Qiang, Blanke, Charles D., Demetri, George D., Heinrich, Michael C., Watson, James C., Hoffman, John P., Okuno, Scott, Kane, John M., von Mehren, Margaret, Eisenberg, Burton L.

Volltext

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor:... von HEINRICH, Michael C, OWZAR, Kouros, BENJAMIN, Robert S, BRAMWELL, Vivien H, DEMETRI, George D, BERTAGNOLLI, Monica M, FLETCHER, Jonathan A, CORLESS, Christopher L, HOLLIS, Donna, BORDEN, Ernest C, FLETCHER, Christopher D. M, RYAN, Christopher W, VON MEHREN, Margaret, BLANKE, Charles D, RANKIN, Cathryn

Volltext

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 von Gillessen, Silke, Attard, Gerhardt, Beer, Tomasz M., Beltran, Himisha, Bjartell, Anders, Bossi, Alberto, Briganti, Alberto, Bristow, Rob G., Chi, Kim N., Clarke, Noel, Davis, Ian D., de Bono, Johann, Drake, Charles G., Duran, Ignacio, Eeles, Ros, Efstathiou, Eleni, Evans, Christopher P., Fanti, Stefano, Feng, Felix Y., Fizazi, Karim, Frydenberg, Mark, Gleave, Martin, Halabi, Susan, Heidenreich, Axel, Heinrich, Daniel, Higano, Celestia (Tia) S., Hofman, Michael S., Hussain, Maha, James, Nicolas, Kanesvaran, Ravindran, Kantoff, Philip, Khauli, Raja B., Leibowitz, Raya, Logothetis, Chris, Maluf, Fernando, Millman, Robin, Morgans, Alicia K., Morris, Michael J., Mottet, Nicolas, Mrabti, Hind, Murphy, Declan G., Murthy, Vedang, Oh, William K., Ost, Piet, O’Sullivan, Joe M., Padhani, Anwar R., Parker, Chris, Poon, Darren M.C., Pritchard, Colin C., Reiter, Robert E., Roach, Mack, Rubin, Mark, Ryan, Charles J., Saad, Fred, Sade, Juan Pablo, Sartor, Oliver, Scher, Howard I., Shore, Neal, Small, Eric, Smith, Matthew, Soule, Howard, Sternberg, Cora N., Steuber, Thomas, Suzuki, Hiroyoshi, Sweeney, Christopher, Sydes, Matthew R., Taplin, Mary-Ellen, Tombal, Bertrand, Türkeri, Levent, van Oort, Inge, Zapatero, Almudena, Omlin, Aurelius

Volltext

Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors von HEINRICH, Michael C, CORLESS, Christopher L, MCDOUGALL, Karen, OU, Wen-Bin, CHEN, Chang-Jie, FLETCHER, Jonathan A, BLANKE, Charles D, DEMETRI, George D, JOENSUU, Heikki, ROBERTS, Peter J, EISENBERG, Burton L, VON MEHREN, Margaret, FLETCHER, Christopher D. M, SANDAU, Katrin

Volltext

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 01... von Eisenberg, Burton L., Harris, Jonathan, Blanke, Charles D., Demetri, George D., Heinrich, Michael C., Watson, James C., Hoffman, John P., Okuno, Scott, Kane, John M., von Mehren, Margaret

Volltext

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial von Corless, Christopher L, Ballman, Karla V, Antonescu, Cristina R, Kolesnikova, Violetta, Maki, Robert G, Pisters, Peter W T, Blackstein, Martin E, Blanke, Charles D, Demetri, George D, Heinrich, Michael C, von Mehren, Margaret, Patel, Shreyaskumar, McCarter, Martin D, Owzar, Kouros, DeMatteo, Ronald P

Volltext

Nutrient acquisition from arable subsoils in temperate climates: A review von Kautz, Timo, Amelung, Wulf, Ewert, Frank, Gaiser, Thomas, Horn, Rainer, Jahn, Reinhold, Javaux, Mathieu, Kemna, Andreas, Kuzyakov, Yakov, Munch, Jean-Charles, Pätzold, Stefan, Peth, Stephan, Scherer, Heinrich W., Schloter, Michael, Schneider, Heike, Vanderborght, Jan, Vetterlein, Doris, Walter, Achim, Wiesenberg, Guido L.B., Köpke, Ulrich

Volltext

Dose-Dependent Effects of Closed-Loop tACS Delivered During Slow-Wave Oscillations on Memory Consolidation von Jones, Aaron P, Choe, Jaehoon, Bryant, Natalie B, Robinson, Charles S H, Ketz, Nicholas A, Skorheim, Steven W, Combs, Angela, Lamphere, Melanie L, Robert, Bradley, Gill, Hope A, Heinrich, Melissa D, Howard, Michael D, Clark, Vincent P, Pilly, Praveen K

Volltext

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer von von Minckwitz, Gunter, Huang, Chiun-Sheng, Mano, Max S, Loibl, Sibylle, Mamounas, Eleftherios P, Untch, Michael, Wolmark, Norman, Rastogi, Priya, Schneeweiss, Andreas, Redondo, Andres, Fischer, Hans H, Jacot, William, Conlin, Alison K, Arce-Salinas, Claudia, Wapnir, Irene L, Jackisch, Christian, DiGiovanna, Michael P, Fasching, Peter A, Crown, John P, Wülfing, Pia, Shao, Zhimin, Rota Caremoli, Elena, Wu, Haiyan, Lam, Lisa H, Tesarowski, David, Smitt, Melanie, Douthwaite, Hannah, Singel, Stina M, Geyer, Charles E

Volltext